image
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
$ 68.82
-3.29 %
$ 31.5 B
Market Cap
14.09
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one GEHC stock under the worst case scenario is HIDDEN Compared to the current market price of 68.8 USD, GE HealthCare Technologies Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one GEHC stock under the base case scenario is HIDDEN Compared to the current market price of 68.8 USD, GE HealthCare Technologies Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one GEHC stock under the best case scenario is HIDDEN Compared to the current market price of 68.8 USD, GE HealthCare Technologies Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart GEHC

image
$95.0$95.0$90.0$90.0$85.0$85.0$80.0$80.0$75.0$75.0$70.0$70.0$65.0$65.0$60.0$60.0$55.0$55.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
19.7 B REVENUE
0.61%
2.62 B OPERATING INCOME
7.80%
2.05 B NET INCOME
30.74%
1.95 B OPERATING CASH FLOW
-7.14%
-914 M INVESTING CASH FLOW
-63.80%
-573 M FINANCING CASH FLOW
-19.87%
4.78 B REVENUE
-10.19%
629 M OPERATING INCOME
-21.47%
588 M NET INCOME
-21.07%
0 OPERATING CASH FLOW
0.00%
-407 M INVESTING CASH FLOW
-69.58%
-286 M FINANCING CASH FLOW
77.60%
Balance Sheet GE HealthCare Technologies Inc.
image
Current Assets 9.9 B
Cash & Short-Term Investments 2.89 B
Receivables 4.36 B
Other Current Assets 2.65 B
Non-Current Assets 23.2 B
Long-Term Investments 373 M
PP&E 2.55 B
Other Non-Current Assets 20.3 B
8.73 %13.19 %8.00 %7.71 %61.24 %Total Assets$33.1b
Current Liabilities 9.55 B
Accounts Payable 3.02 B
Short-Term Debt 1.62 B
Other Current Liabilities 4.91 B
Non-Current Liabilities 14.9 B
Long-Term Debt 310 M
Other Non-Current Liabilities 14.6 B
12.37 %6.62 %20.11 %59.64 %Total Liabilities$24.4b
EFFICIENCY
Earnings Waterfall GE HealthCare Technologies Inc.
image
Revenue 19.7 B
Cost Of Revenue 11.5 B
Gross Profit 8.2 B
Operating Expenses 5.58 B
Operating Income 2.62 B
Other Expenses 575 M
Net Income 2.05 B
20b20b18b18b16b16b14b14b12b12b10b10b8b8b6b6b4b4b2b2b0020b(11b)8b(6b)3b(575m)2bRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
41.71% GROSS MARGIN
41.71%
13.34% OPERATING MARGIN
13.34%
10.13% NET MARGIN
10.13%
23.60% ROE
23.60%
6.02% ROA
6.02%
8.29% ROIC
8.29%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis GE HealthCare Technologies Inc.
image
2b2b2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m00202020202021202120222022202320232024202420252025
Net Income 2.05 B
Depreciation & Amortization 580 M
Capital Expenditures -401 M
Stock-Based Compensation 125 M
Change in Working Capital -59 M
Others -1.2 B
Free Cash Flow 1.55 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets GE HealthCare Technologies Inc.
image
Wall Street analysts predict an average 1-year price target for GEHC of $89.4 , with forecasts ranging from a low of $73 to a high of $100 .
GEHC Lowest Price Target Wall Street Target
73 USD 6.07%
GEHC Average Price Target Wall Street Target
89.4 USD 29.87%
GEHC Highest Price Target Wall Street Target
100 USD 45.31%
Price
Max Price Target
Min Price Target
Average Price Target
100100959590908585808075757070656560605555Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.04% DIVIDEND YIELD
0.035 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
0.1400.1400.1200.1200.1000.1000.0800.0800.0600.0600.0400.0400.0200.0200.0000.0000.030.0350.030.030.030.0350.030.030.030.120.030.130.030.04202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 8
6. Ownership
Insider Ownership GE HealthCare Technologies Inc.
image
Sold
0-3 MONTHS
185 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
388 K USD 2
9-12 MONTHS
7.52 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know Most of the MedTech players have adjusted their 2025 forecasts in response to rising tariff pressure. zacks.com - 2 weeks ago
Here's Why GE HealthCare Stock Sank in April Shares in medical equipment company GE HealthCare Technologies (GEHC 4.29%) declined by 12.9% in April, according to data provided by S&P Global Market Intelligence. The key reason for the decline comes from the "Liberation Day" tariffs announced by President Donald Trump at the start of the month. fool.com - 2 weeks ago
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatmen. businesswire.com - 2 weeks ago
GE HealthCare's Strong Q1 Took Back Seat To Tariffs, Analyst Sees 2026 Tariff Impact Less Than 2025 On Wednesday, GE HealthCare  GEHC reported first-quarter 2025 adjusted EPS of $1.01, which beat the consensus of 91 cents. It was up from 90 cents a year ago. benzinga.com - 2 weeks ago
GE Healthcare sees tariffs costing $500 million in 2025, then much less next year GE Healthcare sees bilateral China tariffs accounting for most of the expected tariff cost, or roughly 75%. marketwatch.com - 2 weeks ago
GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing. zacks.com - 2 weeks ago
GE HealthCare Blames Tariffs For Lowering 2025 Profit Outlook, Initiates Stock Buyback On Wednesday, GE HealthCare GEHC reported first-quarter 2025 adjusted EPS of $1.01, which beat the consensus of 91 cents. It was up from 90 cents a year ago. benzinga.com - 2 weeks ago
GE HealthCare Technologies Inc. (GEHC) Q1 2025 Earnings Call Transcript GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q1 2025 Earnings Conference Call April 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Jason Bednar - Piper Sandler Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan David Roman - Goldman Sachs Joanne Wuensch - Citi Craig Bijou - BofA Securities Anthony Petrone - Mizuho Financial Group Operator Good day, and thank you for standing by. Welcome to the GE HealthCare First Quarter 2025 Earnings Conference Call. seekingalpha.com - 2 weeks ago
Tariffs Weigh on GE HealthCare Outlook Here's our initial take on GE HealthCare's (GEHC 3.14%) first-quarter financial report. fool.com - 2 weeks ago
GE HealthCare beats on earnings, slashes full year outlook due to tariffs GE HealthCare reported better-than-expected first-quarter results, beating analysts' estimates on top and bottom lines. The company slashed its annual forecast to account for the impact of President Donald Trump's tariff policy. cnbc.com - 2 weeks ago
GE HealthCare (GEHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 2 weeks ago
GE HealthCare Technologies (GEHC) Q1 Earnings and Revenues Top Estimates GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.90 per share a year ago. zacks.com - 2 weeks ago
8. Profile Summary

GE HealthCare Technologies Inc. GEHC

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 31.5 B
Dividend Yield 0.04%
Description GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Contact 500 West Monroe Street, Chicago, IL, 60661 https://www.gehealthcare.com
IPO Date Dec. 15, 2022
Employees 53000
Officers Mr. Jahid Khandaker Chief Information Officer Ms. Carolynne Borders Chief Investor Relations Officer Dr. Taha Kass-Hout M.D., M.S. Chief Science & Technology Officer Mr. Adam Y. Holton Chief People Officer Mr. George Andrew Newcomb Controller & Chief Accounting Officer Mr. Roland Rott President & Chief Executive Officer of Imaging Mr. James K. Saccaro Vice President & Chief Financial Officer Ms. Rana Strellis Chief Corporate Marketing & Communications Officer Mr. Peter J. Arduini President, Chief Executive Officer & Director Mr. Frank R. Jimenez Esq. Vice President, General Counsel & Corporate Secretary